Impact story: Medicines Patent Pool
Review of the Pibrentasvir patent landscape: A scoping report
Review of the Glecaprevir patent landscape: A scoping report
Unitaid’s approach to intellectual property
Thematic Narrative for Reproductive, Maternal, Newborn and Child Health (RMNCH)
Discussion Paper: Ensuring that essential medicines are also affordable medicines: challenges and options
Discussion Paper: An economic perspective on delinking the cost of R&D from the price of medicines
Hepatitis C medicines technology and market landscape